Drawing for SOLVD HEALTH

USPTO serial 90018315

SOLVD HEALTH

Reviewed by CopyMark Law Group

Reg. 7170077Status 700Registered
Filing date
Status date
Registration date
Sep 19, 2023
Examiner
NADELMAN, ANDREA KOYNER
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SOLVD HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William S. Fultz

William S. Fultz WOMBLE BOND DICKINSON (US) LLP555 FAYETTEVILLE STREET, SUITE 1100RALEIGH, NC 27601UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medical testing kits comprised of medical diagnostic reagents and assays for detecting genetic predispositions to addiction or substance use disorder for health and medical risk assessment purposes; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancerACTIVENov 25, 2020
010Apparatus for DNA and RNA testing for medical purposes; Medical diagnostic instruments for the analysis of body fluids; Medical test kits for detecting cancer and precancerous cells composed of medical specimen collection tools and devices for the collection of biological specimens, namely, one or more of lancets, swabs for collecting body fluids, test tubes, sanitizing wipes, collection envelopes, and instruction manuals; Medical testing apparatus and instruments for detecting genetic predispositions for health and medical risk assessment purposes; Medical testing kits for use in predicting an individual's risk of addiction or substance use disorder composed of medical devices, machines, apparatus, diagnostic apparatus, instruments, and specimen collection tools for the collection of DNA, namely, one or more of handheld devices containing swabs for obtaining buccal cells, lancets, swabs, saliva collection tubes, test tubes, wipes, collection envelopes, and instruction manuals; Medical testing kits containing biological specimen collection devices in the nature of handheld devices containing swabs for obtaining buccal cells, lancets, swabs, saliva collection tubes, test tubes, wipes, and collection envelopes for the collection of cell tissue containing nucleic acids for use in testing a patient's risk of addiction or substance use disorderACTIVENov 25, 2020
044Medical diagnostic testing, monitoring, and reporting services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical screening; Genetic testing for medical purposes; Drug use testing services; Providing medical testing and reporting services pertaining to a patient's risk of addiction or substance use disorder for diagnostic or treatment purposes; Providing cancer screening services; Medical analysis services for the detection of cancer and precancerous cells for diagnostic or treatment purposesACTIVENov 25, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 19, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 19, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 15, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 14, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 7, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 4, 2023IUAFUSE AMENDMENT FILED—
Aug 4, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 17, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 16, 2023EX4GSOU EXTENSION 4 GRANTED—
Feb 16, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 1, 2023EXT4SOU EXTENSION 4 FILED—
Feb 1, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 13, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 11, 2022EX3GSOU EXTENSION 3 GRANTED—
Jul 11, 2022EXT3SOU EXTENSION 3 FILED—
Jul 11, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 9, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 7, 2022EX2GSOU EXTENSION 2 GRANTED—
Feb 7, 2022EXT2SOU EXTENSION 2 FILED—
Feb 7, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 3, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 30, 2021EX1GSOU EXTENSION 1 GRANTED—
Jul 30, 2021EXT1SOU EXTENSION 1 FILED—
Jul 30, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 9, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 15, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 15, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 25, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 12, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 10, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 10, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 10, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 21, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 2020DOCKASSIGNED TO EXAMINER—
Jul 21, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 27, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance